Pure Global AI
ANVISA registration 80134860303Valid until Dec 11, 2033

ANTI-HUMAN GLOBULIN (COOMBS)

ANVISA Registration Number: 80134860303GRIFOLS BRASIL LTDAMEDION GRIFOLS DIAGNOSTICS AGRisk Class III
Verified
Device names
Technical name
ANTI-HUMAN GLOBULIN (COOMBS)
View exact technical-name matches →
PT: GLOBULINA ANTI-HUMANA (COOMBS)
Commercial name
Anti-IgG
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
80134860303
Process Number
25351125233202360
CNPJ
02513899000171
Company information
Registration Holder
GRIFOLS BRASIL LTDA
Manufacturer
MEDION GRIFOLS DIAGNOSTICS AG
Manufacturing Country
Switzerland
PT: SUÍÇA
Dates and status
Publication Date
Dec 11, 2023
Validity
11/12/2033
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80134860303 and manufactured by MEDION GRIFOLS DIAGNOSTICS AG. The registration is held by GRIFOLS BRASIL LTDA with validity until Dec 11, 2033.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.